GENETIC TESTING FOR ALL BREAST CANCER PATIENTS (GET FACTS)
Trial Description
This study is designed to determine the impact of a novel genetic counseling method on
surgical decisions in individuals with newly diagnosed breast cancer
This research study involves an expedited and surgery-specific form of genetic counseling.
The names of the study methods involved in this trial are/is:
- Quantitative genetic counseling (discussion is guided by tables and graphs)
- Standard genetic counseling
Eligibility Requirements
Inclusion Criteria
- Patients with a new breast cancer diagnosis (invasive or in-situ) considering genetic
testing
- Patients with good understanding of written and spoken English
- Patients with apparent cognitive capacity to make surgical decisions for themselves
- Patients who are medically cleared for surgery
- Patients must be at least age 18 but under 79
Exclusion Criteria
- Previous breast cancer diagnosis (invasive or DCIS)
- Metastatic breast cancer
- Patients who have received prior broad-based panel testing (prior BRCA1/2 testing with
negative results allowed)
- Bilateral breast cancer
- Known medical or surgical contraindication to contralateral mastectomy
- Hematologic malignancy necessitating skin biopsy/fibroblast culture for germline
genetic testing malignancy other than cervical cis or basal or squamous cell skin
cancers.